Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Karen H. Lu Ana Maria Gonzalez-Angulo Gordon B. Mills |
| Publication date | July 6, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |